Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2629 stock hub

HKG/2629 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2629is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.7B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2629

In the news

Latest news · HKG/2629

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROEn/a

P25 -14.7P50 2P75 9.4

ROICn/a

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2629 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	347
Employees Change	-5%
Employees Change Percent	-1.42
Enterprise value	HKD 3.1B
Exchange	Hong Kong Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	HKD 3.7B
Price	HKD 12.41
Price currency	HKD
Rev Per Employee	479,308.81x
Sector	Healthcare
Sic	3841
Symbol	hkg/2629
Website	https://mirxes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.33%
EV Earnings	-5.14x
EV/FCF	-12.14x
EV/Sales	18.48x
FCF yield	-6.91%
P/B ratio	4.07x
P/S ratio	22.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-288.28%
Gross margin	53.45%
Gross Profit	HKD 88.9M
Gross Profit Growth	21.33%
Net Income	HKD -598.4M
Pretax Margin	-375.27%
Profit Per Employee	HKD -1.7M
ROCE	-51.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	19.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	HKD 1.3B
Cash	HKD 850.6M
Current Assets	HKD 1B
Current Liabilities	HKD 259.5M
Debt	HKD 181.7M
Debt Equity	HKD 0.2
Debt FCF	HKD -0.72
Equity	HKD 899M
Interest Coverage	-4.1
Liabilities	HKD 382.2M
Long Term Assets	HKD 265.2M
Long Term Liabilities	HKD 122.7M
Net Cash	HKD 668.9M
Net Cash By Market Cap	HKD 18.26
Net Debt Equity	HKD -0.74
Tangible Book Value	HKD 770.1M
Tangible Book Value Per Share	HKD 2.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.91
Net Working Capital	HKD -22.1M
Quick ratio	3.66
Working Capital	HKD 758.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	41.38
50-day SMA	22.84
50-day SMA vs 200-day SMA	50under200
All Time High	77.3
All Time High Change	-83.95%
All Time High Date	2025-10-06
All Time Low	12.28
All Time Low Change	1.06%
All Time Low Date	2026-03-27
ATR	1.77
Beta1y	1.04
Ch YTD	-71.82
High	12.41
High52	77.3
High52 Date	2025-10-06
High52ch	-83.95%
Low	12.41
Low52	12.28
Low52 Date	2026-03-27
Low52ch	1.06%
Ma50ch	-45.68%
Price vs 200-day SMA	-70.01%
RSI	31.69
RSI Monthly	0
RSI Weekly	23.44
Sharpe ratio	-0.79x
Sortino ratio	-1.14
Total Return	-14.17%
Tr YTD	-71.82
Tr1m	-23.21%
Tr1w	-4.69%
Tr3m	-71.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -525M
Operating margin	-315.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,822,614%
Net Borrowing	237,748,871.4
Shares Insiders	41.16%
Shares Institutions	12.54%
Shares Out	295,185,217
Shares Qo Q	0%
Shares Yo Y	14.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -374.7M
Average Volume	10,081,952.5x
Bv Per Share	3
CAPEX	HKD -9.7M
Ch1m	-23.21
Ch1w	-4.69
Ch3m	-71.8
Ch6m	-79.79
Change	0%
Change From Open	0
Close	12.41
Days Gap	0
Depreciation Amortization	45,411,532.4
Earnings Date	2026-05-15
EBIT	HKD -525M
EBITDA	HKD -479.5M
EPS	HKD -4.38
F Score	4
FCF	HKD -253.1M
FCF EV Yield	-8.23x
FCF Per Share	HKD -0.86
Financing CF	1,104,081,667
Fiscal Year End	December
Founded	2,014
Income Tax	HKD -26.6M
Investing CF	-315,877,082
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-06-30
Ma150	44.13
Ma150ch	-71.88%
Ma20	13.88
Ma20ch	-10.61%
Net CF	543,455,634
Next Earnings Date	2026-05-15
Open	12.41
Ppne	173,864,059.5
Price Date	2026-05-06
Ptbv Ratio	4.76
Relative Volume	5.44x
Revenue	166,320,156x
SBC By Revenue	73.09x
Share Based Comp	121,557,426
Tax By Revenue	-16.01x
Tr6m	-79.79%
Volume	0
Z Score	10.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2629 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2629?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.5%

Share of float held by funds and institutions

Insider ownership

+41.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+14.2%

Negative means the company is buying back shares.

Technical

HKG/2629 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.7

Neutral momentum band

Price vs 200-day MA

-70.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2629

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2629 stock rating?

hkg/2629 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2629 analysis?

The full report lives at /stocks/hkg/2629/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2629?

The latest report frames hkg/2629 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2629 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.